Folgen
Pradeep Thiyyagura
Pradeep Thiyyagura
Bioinformatics Research Analyst II, Banner Alzheimer's Institute
Bestätigte E-Mail-Adresse bei bannerhealth.com
Titel
Zitiert von
Zitiert von
Jahr
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
JF Arboleda-Velasquez, F Lopera, M O’Hare, S Delgado-Tirado, C Marino, ...
Nature medicine 25 (11), 1680-1683, 2019
4232019
Using positron emission tomography and florbetapir F 18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease
AS Fleisher, K Chen, X Liu, A Roontiva, P Thiyyagura, N Ayutyanont, ...
Archives of neurology 68 (11), 1404-1411, 2011
3992011
Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study
DC Dean, BA Jerskey, K Chen, H Protas, P Thiyyagura, A Roontiva, ...
JAMA neurology 71 (1), 11-22, 2014
2922014
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study
AS Fleisher, K Chen, YT Quiroz, LJ Jakimovich, MG Gomez, CM Langois, ...
The Lancet Neurology 11 (12), 1057-1065, 2012
2722012
Cerebral blood flow in Alzheimer’s disease
AE Roher, JP Debbins, M Malek-Ahmadi, K Chen, JG Pipe, S Maze, ...
Vascular health and risk management, 599-611, 2012
2362012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
AS Fleisher, K Chen, X Liu, N Ayutyanont, A Roontiva, P Thiyyagura, ...
Neurobiology of aging 34 (1), 1-12, 2013
2132013
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study
AS Fleisher, K Chen, YT Quiroz, LJ Jakimovich, MG Gomez, CM Langois, ...
JAMA neurology 72 (3), 316-324, 2015
1892015
Genetic susceptibility for Alzheimer disease neuritic plaque pathology
JM Shulman, K Chen, BT Keenan, LB Chibnik, A Fleisher, P Thiyyagura, ...
JAMA neurology 70 (9), 1150-1157, 2013
1862013
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region
K Chen, A Roontiva, P Thiyyagura, W Lee, X Liu, N Ayutyanont, H Protas, ...
Journal of Nuclear Medicine 56 (4), 560-566, 2015
1482015
Brain imaging and blood biomarker abnormalities in children with autosomal dominant Alzheimer disease: a cross-sectional study
YT Quiroz, AP Schultz, K Chen, HD Protas, M Brickhouse, AS Fleisher, ...
JAMA neurology 72 (8), 912-919, 2015
1212015
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia
MN Sabbagh, K Chen, J Rogers, AS Fleisher, C Liebsack, D Bandy, ...
Alzheimer's & Dementia 11 (8), 994-1004, 2015
692015
Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers
K Adamczuk, AS De Weer, N Nelissen, K Chen, K Sleegers, K Bettens, ...
NeuroImage: Clinical 2, 512-520, 2013
632013
Fat-free body mass but not fat mass is associated with reduced gray matter volume of cortical brain regions implicated in autonomic and homeostatic regulation
CM Weise, P Thiyyagura, EM Reiman, K Chen, J Krakoff
Neuroimage 64, 712-721, 2013
562013
Overfeeding over 24 hours does not activate brown adipose tissue in humans
M Schlögl, P Piaggi, P Thiyyagura, EM Reiman, K Chen, C Lutrin, ...
The Journal of Clinical Endocrinology & Metabolism 98 (12), E1956-E1960, 2013
512013
A potential role for the midbrain in integrating fat‐free mass determined energy needs: An H215O PET study
CM Weise, P Thiyyagura, EM Reiman, K Chen, J Krakoff
Human brain mapping 36 (6), 2406-2415, 2015
242015
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
S Rios‐Romenets, F Lopera, KM Sink, N Hu, Q Lian, H Guthrie, J Smith, ...
Alzheimer's & Dementia 16 (7), 1023-1030, 2020
162020
Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei—a combined MRI and H215O PET study
CM Weise, P Thiyyagura, EM Reiman, K Chen, J Krakoff
Neuroimage 60 (1), 592-600, 2012
152012
Predicting imminent progression to clinically significant memory decline using volumetric MRI and FDG PET
CM Stonnington, Y Chen, CR Savage, W Lee, RJ Bauer III, S Sharieff, ...
Journal of Alzheimer's Disease 63 (2), 603-615, 2018
132018
Interaction between BDNF Val66Met and APOE4 on biomarkers of Alzheimer’s disease and cognitive decline
CM Stonnington, SN Velgos, Y Chen, S Syed, M Huentelman, ...
Journal of Alzheimer's Disease 78 (2), 721-734, 2020
112020
Visualizing Alzheimer's disease progression in low dimensional manifolds
K Seo, R Pan, D Lee, P Thiyyagura, K Chen
Heliyon 5 (8), 2019
102019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20